Novo Nordisk's plan to gain ground in the GLP-1 space is slowly taking shape.

The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and ...

Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide ...

Novo Nordisk is considering additional regulatory filings for CagriSema – already submitted in the US for obesity – after the drug outperformed Ozempic in a head-to-head diabetes study.

A study analysing online reviews found that many people keep taking Ozempic for weight loss if they feel it is working, even when side effects continue. Instead, people were more likely to discontinue ...

Time for Ozempic to walk the plank? Top dietitians in Australia this week are waving a red flag about an unforeseen impact of ...

Ozempic and similar weight loss drugs offer major benefits for obesity and heart health, but side effects, muscle loss, and ...

Weight loss drugs can be life changing but are not without risks,' says Dr Vishnu Radhakrishnan as he explains the truth ...

Novo Nordisk, the Danish manufacturer of weight-loss drugs Ozempic and Wegovy, has a large market share in the US. But it's not enough to put pressure on US President Donald Trump's administration ...

Feb 4 (Reuters) - Novo Nordisk said on Wednesday it will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said ...

Novo Nordisk brought in Justin Long and John Hodgman, who had been in the Apple "Get A Mac" ads from 20 years ago, to star in ...